Pneumococcal Infections
Information
- Disease name
- Pneumococcal Infections
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00508742 | Completed | Phase 3 | Study Evaluating the Impact of a 13-valent Pneumococcal Conjugate Vaccine on Nasopharyngeal Colonization | December 2007 | August 2011 |
| NCT00000933 | Completed | Effects of MAC Preventive Therapy on Disease-Causing Bacteria in HIV-Infected Patients: A Substudy of CPCRA 048 | July 2000 | ||
| NCT00013871 | Completed | N/A | Pneumococcal Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Receiving Anti-HIV Drugs | November 2004 | |
| NCT03571607 | Completed | Phase 3 | A Safety And Immunogenicity Study Of A 13-valent Pneumococcal Conjugate Vaccine In Japanese Subjects Aged 6 To 64 Years. | July 12, 2018 | November 16, 2018 |
| NCT03574389 | Completed | Phase 3 | A Study Assessing 13-valent Pneumococcal Conjugate Vaccine in Healthy Chinese Infants and Young Children | June 23, 2018 | October 13, 2023 |
| NCT03615482 | Completed | Phase 3 | A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (V114-021/PNEU-FLU) | September 14, 2018 | June 24, 2019 |
| NCT03620162 | Completed | Phase 3 | A Study to Evaluate the Interchangeability of V114 and Prevnar 13™ in Healthy Infants (V114-027/PNEU-DIRECTION) | October 18, 2018 | December 14, 2020 |
| NCT03642847 | Completed | Phase 1 | Trial to Evaluate the Safety and Immunogenicity of Multivalent Pneumococcal Vaccines in Japanese Adults 18 to 49 Years of Age | August 29, 2018 | March 29, 2019 |
| NCT03692871 | Completed | Phase 3 | A Study to Evaluate the Safety and Tolerability of V114 and Prevnar 13™ in Healthy Infants (V114-031/PNEU-LINK) | December 14, 2018 | March 26, 2021 |
| NCT03731182 | Completed | Phase 3 | A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 in Children With Sickle Cell Disease (V114-023/PNEU-SICKLE) | January 23, 2019 | June 8, 2020 |
| NCT03848065 | Completed | Phase 1 | Safety, Tolerability, and Immunogenicity of V114 in Healthy Japanese Infants (V114-028) | April 2, 2019 | June 24, 2020 |
| NCT03885934 | Completed | Phase 3 | Safety and Immunogenicity of Catch-up Vaccination Regimens of V114 (V114-024) | June 25, 2019 | December 9, 2020 |
| NCT03893448 | Completed | Phase 3 | Safety, Tolerability, and Immunogenicity of V114 in Healthy Infants (V114-029) | June 19, 2019 | May 24, 2021 |
| NCT03921424 | Completed | Phase 3 | Safety and Immunogenicity of V114 in Children Infected With Human Immunodeficiency Virus (HIV) (V114-030/PNEU-WAY PED) | November 5, 2019 | May 3, 2021 |
| NCT03950622 | Completed | Phase 3 | Safety and Immunogenicity of V114 in Healthy Adults (V114-019/PNEU-AGE) | June 13, 2019 | March 30, 2020 |
| NCT03950856 | Completed | Phase 3 | Lot-to-Lot Consistency of V114 in Healthy Adults (V114-020) | June 12, 2019 | April 3, 2020 |
| NCT04016714 | Completed | Phase 3 | Safety, Tolerability, and Immunogenicity of a 3-dose Regimen of V114 in Healthy Infants (PNEU-PED-EU-2/V114-026) | August 28, 2019 | October 29, 2021 |
| NCT04031846 | Completed | Phase 3 | Safety, Tolerability, and Immunogenicity of V114 in Healthy Infants (V114-025) | September 4, 2019 | August 5, 2021 |
| NCT04100772 | Completed | Phase 1 | Phase I Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above | May 18, 2020 | August 23, 2022 |
| NCT04183322 | Completed | PCV13 in Non-pregnant Papua New Guinean Women | May 10, 2016 | April 10, 2018 | |
| NCT04384107 | Completed | Phase 3 | Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 in Healthy Japanese Infants (V114-033) | July 1, 2020 | December 1, 2021 |
| NCT04841369 | Completed | Phase 3 | Phase III Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above (PICTPCV13i) | April 13, 2021 | September 20, 2022 |
| NCT04912297 | Completed | Immunity to Serotype 19A Streptococcus Pneumoniae in Children Vaccinated With PCV10 | November 12, 2009 | May 7, 2013 | |
| NCT04989465 | Completed | Phase 4 | A Clinical Trial of 23-valent Pneumococcal Polysaccharide Vaccine | September 10, 2021 | September 13, 2021 |
| NCT05229081 | Completed | N/A | Impact of Pharmacist-led Educational Intervention on Pneumococcal Vaccination Rates in Cancer Patients | July 19, 2019 | February 15, 2021 |
| NCT05477693 | Completed | Phase 4 | Immunogenicity and Safety of 23-valent Pneumococcal Polysaccharide Vaccine | October 25, 2022 | April 10, 2023 |
| NCT05731115 | Completed | Phase 4 | Lot-to-lot Consistency of 23-valent Pneumococcal Polysaccharide Vaccine | February 27, 2023 | May 5, 2023 |
| NCT00127153 | Completed | Phase 3 | A Study of V110 a Pneumococcal Vaccine in Healthy Adults (V110-013) | March 2005 | May 2005 |
| NCT00137605 | Completed | Phase 1/Phase 2 | Early Versus Delayed Pneumococcal Vaccination in HIV | September 2004 | October 2007 |
| NCT00142389 | Completed | Phase 1/Phase 2 | Mother's Gift Project | August 2004 | December 2006 |
| NCT00153543 | Completed | Phase 1 | Immunogenicity and Reactogenicity of Pneumococcal Polysaccharide and Conjugate Vaccines in Native Elders | May 2002 | June 2003 |
| NCT00164411 | Completed | Phase 1 | Pneumococcal Conjugate Vaccine With Pneumococcal Polysaccharide Vaccine and Tetanus/Diphtheria Vaccine | January 2004 | March 2005 |
| NCT00170612 | Completed | Phase 2 | Pneumococcal Vaccination of Fiji Infants | November 2005 | August 2008 |
| NCT00195390 | Completed | Study Investigating Administration of Prevenar for Post-Marketing Surveillance | July 2004 | July 2008 | |
| NCT00195611 | Completed | Study of Streptococcus Pneumoniae in Nose and Throats of Infants With Acute Otitis Media | September 2005 | June 2006 | |
| NCT00197808 | Completed | Phase 4 | Response of United Kingdom (UK) Infants to a Reduced Primary Schedule With Meningococcal C and Pneumococcal Conjugate Vaccines | April 2005 | January 2010 |
| NCT00205803 | Completed | Phase 1/Phase 2 | Study Evaluating Pneumococcal Vaccine in Healthy Infants | September 2004 | May 2007 |
| NCT00273325 | Completed | Immunogenicity of PCV-7 Vaccine in VLBW Infants | July 2004 | March 2009 | |
| NCT00276107 | Completed | Phase 4 | Study Evaluating Prevenar Vaccine in Healthy Infants | December 2004 | December 2005 |
| NCT00294021 | Completed | Long-term Impact of Pneumococcal Conjugate Vaccine on Carriage | March 2006 | April 2008 | |
| NCT00304382 | Completed | Phase 4 | Humoral Determinants of Immunity to Pneumococcal Infection | January 1, 2003 | June 1, 2012 |
| NCT00378417 | Completed | Phase 3 | Efficacy Trial of Two Pneumococcal Conjugate Vaccines (PncCRM and PncOMPC) for Prevention of Acute Otitis Media Due to Vaccine Serotypes | March 1995 | March 1999 |
| NCT00427895 | Completed | Phase 3 | Study Comparing a 13-valent Pneumococcal Conjugate Vaccine With 23-valent Pneumococcal Polysaccharide Vaccine in Adults | February 27, 2007 | August 1, 2011 |
| NCT00452452 | Completed | Phase 3 | Study Evaluating 13-valent Pneumococcal Conjugate Vaccine Catch-Up Regimens in Older Infants and Children | July 2007 | March 2008 |
| NCT00452790 | Completed | Phase 3 | Study Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants in India | June 2007 | February 2010 |
| NCT00479323 | Completed | Phase 1 | Pneumococcal Reference Standard | June 2007 | August 2008 |
| NCT00488371 | Completed | Study Evaluating Streptococcus Pneumoniae Nasopharyngeal Carriage Rate in Children Receiving Prevnar® | November 2006 | April 2007 | |
| NCT00488800 | Completed | Safety and Local Tolerability of Prevenar in Indian Children | July 2006 | January 2007 | |
| NCT00488826 | Completed | Phase 1 | Study Evaluating 7-Valent Pneumococcal Conjugate Vaccine in Healthy Infants | October 2005 | May 2007 |
| NCT00492557 | Completed | Phase 3 | Study Evaluating Safety and Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine With Influenza Vaccine in Adults | September 2007 | February 2008 |
| NCT00500266 | Completed | Phase 3 | Study Evaluating Safety of 13-Valent Pneumococcal Conjugate Vaccine in Healthy Elderly Subjects | May 2008 | May 2009 |
| NCT00000829 | Completed | Phase 1 | A Double-Blind Placebo-Controlled Trial of the Safety and Immunogenicity of a Seven Valent Pneumococcal Conjugate Vaccine in Presumed HIV-Infected Infants | October 1999 | |
| NCT00546572 | Completed | Phase 3 | Study Evaluating The Safety, Tolerability And Immunogenicity Of A 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) | November 2007 | July 2010 |
| NCT00625677 | Completed | Phase 4 | Study to Evaluate the Immune Response of United Kingdom (UK) Infants Receiving DTaP/Hib/IPV, Meningococcal C Conjugate and Pneumococcal Conjugate Vaccines, Antibody Persistence and Responses to Booster Doses in the Second Year of Life | February 2008 | March 2010 |
| NCT00714064 | Completed | Phase 3 | PneuMum: Pneumococcal Vaccination of Australian Indigenous Mothers | June 2006 | July 2011 |
| NCT00744263 | Completed | Phase 4 | Study Evaluating the Effiacy of a 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in Adults | September 2008 | October 2013 |
| NCT00873431 | Completed | Phase 1 | Open-Label Study Assessing The Safety, Immunogenicity and Dose Response of IC47 | March 2009 | February 2010 |
| NCT00962780 | Completed | Phase 3 | Safety and Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in HIV-Infected Subjects 6 Years of Age or Older Who Are Naive to Pneumococcal Vaccine | March 2010 | April 2013 |
| NCT00963235 | Completed | Phase 3 | Safety & Immunogenicity of 13vPnC in HIV-Infected Subjects Aged 18 or Older Who Were Previously Immunized With 23vPS | November 2009 | May 2012 |
| NCT01193582 | Completed | Phase 4 | A Study To Assess The Safety And Effectiveness Of Prevenar In Chinese Children Who Have Not Previously Received A Vaccine Against Pneumococcal Bacteria | September 2010 | September 2012 |
| NCT01215175 | Completed | Phase 1 | Safety and Tolerability Study for the Pneumococcal Conjugate Vaccine V114 Versus Prevnar™ (V114-001) | September 25, 2009 | January 5, 2011 |
| NCT01215188 | Completed | Phase 2 | A Study of Pneumococcal Conjugate Vaccine (V114) Compared to a Marketed Vaccine (V114-003) | October 14, 2010 | July 31, 2012 |
| NCT01311024 | Completed | Indirect Effects of Pneumococcal Vaccine on Nasopharyngeal Carriage | April 2011 | December 2017 | |
| NCT01432262 | Completed | Phase 3 | 13-valent Pneumococcal Conjugate Vaccine Study in Adults => 50 Years of Age in Mexico | July 2011 | December 2011 |
| NCT01444001 | Completed | Phase 1 | Study of an Investigational Pneumococcal Vaccine in Healthy Adult Volunteers | February 2007 | August 2007 |
| NCT01444339 | Completed | Phase 1 | Study of Two Investigational Pneumococcal Vaccines in Healthy Adults | February 2010 | September 2010 |
| NCT01444352 | Completed | Phase 1 | Study of an Investigational Pneumococcal Vaccine at Three Dose Levels in Healthy Adults | June 2010 | January 2011 |
| NCT01446926 | Completed | Phase 1 | Study of Investigational Pneumococcal Vaccine in Healthy Adults, Toddlers and Infants | September 2011 | June 2013 |
| NCT01513551 | Completed | Phase 2 | The Safety, Tolerability, and Immunogenicity Profiles of a Single Dose of V114, PNEUMOVAX® 23, or PREVNAR 13® in Adults 50 Years of Age or Older (V114-002) | March 13, 2012 | February 15, 2013 |
| NCT01577771 | Completed | Phase 4 | Immunogenicity and Reactogenicity of PCV13 Among Infants and Children in Burkina Faso | February 2013 | May 2014 |
| NCT01899365 | Completed | An Incitative Multifaceted PROcedure for Pneumococcal Vaccination at the Emergency Department | November 2015 | October 2017 | |
| NCT02037984 | Completed | Phase 1/Phase 2 | Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-004) | January 28, 2014 | July 1, 2016 |
| NCT02079207 | Completed | Phase 3 | Study Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine | December 2013 | March 2015 |
| NCT02116998 | Completed | Phase 2 | Safety, Tolerability, and Efficacy Study of Prophylactic S. Pneumoniae Vaccine Following Challenge With S. Pneumoniae | September 2014 | April 2016 |
| NCT02123433 | Completed | Phase 3 | Serological Response to Antipneumococcal Vaccination and Impact on Streptococcus Pneumoniae Nasal Carriage in HIV Adults | December 2011 | October 2013 |
| NCT02201030 | Completed | Phase 3 | Immunogenicity and Safety Study of NBP606 in Healthy Infants | September 6, 2014 | October 21, 2016 |
| NCT02225327 | Completed | Phase 4 | MF59-adjuvanted Influenza Vaccine and 23-valent Pneumococcal Polysaccharide Vaccine | October 2013 | January 2014 |
| NCT02225587 | Completed | Phase 3 | Evaluation of the Safety and Immunogenicity of Sequential Administration of Prevnar 13™ and Pneumovax™ 23 in Healthy Participants 50 Years of Age and Older (V110-029) | August 28, 2014 | July 6, 2015 |
| NCT02451969 | Completed | Phase 3 | Safety and Immunogenicity Study of 23-valent Pneumococcal Polysaccharide Vaccine in Healthy Children, Adults and Elderly | April 2015 | February 2017 |
| NCT02531373 | Completed | Phase 1/Phase 2 | A Study to Evaluate the Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-005) | September 15, 2015 | April 14, 2017 |
| NCT02547649 | Completed | Phase 2 | Safety, Tolerability, and Immunogenicity of Two Formulations of V114 in Healthy Adults 50 Years of Age or Older (V114-006) | October 8, 2015 | January 20, 2016 |
| NCT02573181 | Completed | Phase 2 | Safety, Tolerability, and Immunogenicity of V114 Compared to Prevnar 13™ in PPSV23-vaccinated Healthy Adults ≥65 Years of Age (V114-007) | October 30, 2015 | January 28, 2016 |
| NCT02582047 | Completed | Phase 4 | Influenza Vaccine and Pneumococcal Vaccine | October 2012 | January 2013 |
| NCT02583373 | Completed | Phase 1 | Safety, Tolerability, Efficacy and Pharmacodynamics of CAL02 in Severe Pneumonia Caused by Streptococcus Pneumoniae | March 21, 2016 | February 20, 2018 |
| NCT02615470 | Completed | N/A | Enhancing a Sustainable Pharmacy-based Immunization Program in Two States | November 2015 | December 2017 |
| NCT02637583 | Completed | Phase 4 | Sequential Versus Simultaneous Pneumococcal Vaccination in Elderly: Immunological Memory and Antibody Levels | October 18, 2017 | November 6, 2023 |
| NCT02787863 | Completed | Phase 4 | Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology | September 6, 2012 | December 31, 2016 |
| NCT02892812 | Completed | Phase 1 | A Phase I Clinical Trial of a 13-valent Pneumococcal Conjugate Vaccine and 14-valent Pneumococcal Conjugate Vaccine in Adults | September 2016 | November 2016 |
| NCT02927444 | Completed | Phase 3 | Immunogenicity and Safety Study of NBP606 in Healthy Toddlers | November 4, 2015 | October 26, 2017 |
| NCT02955160 | Completed | Phase 1 | A Phase 1, Randomized, Controlled, Observer-blinded Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Conjugate Vaccine in Healthy Adults Aged 18 to 49 Years | November 3, 2016 | August 1, 2017 |
| NCT02987972 | Completed | Phase 2 | A Study to Evaluate the Safety, Tolerability, and Immunogenicity of Two Lots of V114 in Healthy Infants (V114-008) | March 21, 2017 | October 4, 2018 |
| NCT03313037 | Completed | Phase 2 | Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Conjugate Vaccine in Adults 60 Through 64 Years of Age | October 10, 2017 | December 10, 2018 |
| NCT03313050 | Completed | Phase 2 | A Trial To Evaluate A Multivalent Pneumococcal Conjugate Vaccine In Healthy Adults 50-85 Years Of Age | October 12, 2017 | May 24, 2019 |
| NCT03480763 | Completed | Phase 3 | A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Followed by PNEUMOVAX™23 in Healthy Adults 50 Years of Age or Older (V114-016/PNEU-PATH) | June 22, 2018 | December 23, 2019 |
| NCT03480802 | Completed | Phase 3 | A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Followed by PNEUMOVAX™23 in Adults Infected With Human Immunodeficiency Virus (HIV) (V114-018) | July 6, 2018 | January 17, 2020 |
| NCT03512288 | Completed | Phase 2 | Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Vaccine in Healthy Infants | April 16, 2018 | February 11, 2020 |
| NCT03547167 | Completed | Phase 3 | A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Followed by PNEUMOVAX™23 in Adults at Increased Risk for Pneumococcal Disease (V114-017/PNEU-DAY) | July 16, 2018 | January 20, 2020 |
| NCT03552445 | Completed | Phase 4 | Immunogenicity and Safety of a Tetanus-diphtheria Vaccine and a 13-valent Pneumococcal Conjugate Vaccine | November 1, 2013 | February 28, 2018 |
| NCT03565900 | Completed | Phase 3 | A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 in Allogeneic Hematopoietic Stem Cell Transplant Recipients (V114-022/PNEU-STEM) | September 12, 2018 | November 4, 2021 |
| NCT05767606 | Not yet recruiting | Phase 4 | Concomitant Administration of the Novavax Vaccine and a 20-valent Pneumococcal Conjugate Vaccine in Adults Aged ≥60 Years | March 2023 | August 2023 |
| NCT04664556 | Recruiting | Invasive Pneumococcal Disease Study | December 13, 2010 | January 1, 2030 | |
| NCT05092386 | Recruiting | Phase 1 | Safety and Immunogenicity Study of a 13-valent Pneumococcal Polysaccharide Conjugate Vaccine | January 3, 2023 | June 6, 2024 |
| NCT05412030 | Recruiting | Phase 2 | A Phase 2 Study to Evaluate the Safety, Tolerability, and Immunogenicity of AFX3772 Vaccine in Healthy Infants | June 16, 2022 | July 9, 2026 |
| NCT05920499 | Recruiting | N/A | The Effect of AUDIT and Feedback on Pneumococcal Vaccination Coverage | September 30, 2023 | October 31, 2024 |
| NCT05667740 | Recruiting | Phase 1 | Safety, Tolerability and Immunogenicity of an Inactivated Whole-cell Pneumococcal Vaccine Gamma-PN3. | January 16, 2023 | September 30, 2023 |
| NCT05380193 | Recruiting | Serotype Distribution in Hospitalized Adult With Pneumococcal Community Acquired Pneumonia in France | May 9, 2022 | January 2025 | |
| NCT05982314 | Recruiting | Phase 1/Phase 2 | Extension Safety and Immunogenicity Study of GPNV-001 | July 17, 2023 | September 30, 2024 |
| NCT05602480 | Recruiting | Phase 1 | Phase I Clinical Trial of a Candidate PCV13 in Healthy People | November 1, 2022 | December 2024 |
| NCT04875819 | Recruiting | Phase 4 | Safety and Immunogenicity Following Meningococcal and Pneumococcal Immunization Among Adult People Living With HIV | April 28, 2021 | December 2026 |
| NCT03550313 | Terminated | Phase 2 | Study to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Vaccine Given With Prevnar 13 in Healthy Infants | June 1, 2018 | November 5, 2020 |
| NCT00368186 | Terminated | Phase 4 | Immunogenicity and Safety Study of Pneumococcal 7-Valent Conjugate Vaccine in Sickle Cell Disease Infants. | May 2001 | November 2002 |
| NCT02972281 | Terminated | N/A | Systematic Search for Primary Immunodeficiency in Adults With Infections | March 2015 | March 2020 |
| NCT03276754 | Terminated | Immunization To Prevent Acute COPD Exacerbations | November 30, 2017 | June 16, 2022 | |
| NCT00099658 | Unknown status | N/A | Safety of and Immune Response to a Pneumococcal Vaccine (PncCV) in HIV Infected and Uninfected Children | April 2005 | June 2014 |
| NCT04214444 | Unknown status | Phase 3 | Evaluation of Prime-boost Anti-pneumococcal Vaccination in Patients With Diffuse Large B Cell Lymphoma Treated With Rituximab | July 3, 2020 | July 3, 2022 |
| NCT02012309 | Unknown status | N/A | Mechanisms of Impaired HIV-associated B Cell and Pneumococcal Vaccine Responses | August 2014 | June 2021 |
| NCT04875858 | Unknown status | Phase 4 | Immunogenicity After Revaccination With 23-valent Pneumococcal Polysaccharide Vaccine: Healthy Elderly People Versus Diabetic Patients | May 1, 2021 | April 30, 2022 |
| NCT04945681 | Unknown status | Phase 4 | Evaluating the Effectiveness of a Pneumococcal Immunisation Campaign in a Camp for Internally Displaced People | November 2021 | December 2023 |
| NCT00310349 | Unknown status | Phase 3 | PneuMum: Pneumococcal Vaccination of Australian Indigenous Mothers to See if it Protects Their Babies From Ear Disease | March 2006 | January 2009 |
| NCT03983616 | Unknown status | Surveillance of Invasive Pneumococcal Infections in Adults (Excluding Meningitis) | April 2014 | April 2020 | |
| NCT05145101 | Unknown status | Pneumococcal Vaccination in Patients With Chronic Lymphocytic Leukaemia | May 7, 2020 | March 31, 2022 | |
| NCT01443117 | Withdrawn | Phase 2 | Evaluating the Safety and Immune Response to Two Pneumococcal Vaccines in HIV-Infected Pregnant Women | ||
| NCT02357823 | Withdrawn | Antibodies and Memory Cells Role After Different Pneumococcal Vaccines in HIV Adults | January 2015 | January 2017 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D011008